Elevra Lithium Provides Ewoyaa Sale Update
BRISBANE, Australia, Oct. 01, 2026 (GLOBE NEWSWIRE) -- North American lithium producer Elevra Lithium Limited (“Elevra”) (ASX:ELV; NASDAQ:ELVR) provides an update on the proposed sale of its interests in the Ewoyaa Lithium Project (“Ewoyaa Project”) in Ghana to Zhejiang Huayou Cobalt Co., Ltd. (“Huayou”) where the Ghanaian Government approval process continues and Huayou has received FIRB approval for the proposed acquisition of Atlantic Lithium Limited (“Atlantic Lithium”).
Covered in this story
What has happened since
- Elevance Health is up 15.3% since this was published, 19 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Elevance Health
- Guggenheim: $421 → $460 by Oct 2027 · Buy via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $ELV yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Elevance Health →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.